文献速递冠心病

确定心绞痛的生理阈值(ORBITA-FIRE):双盲随机安慰剂对照研究

Determining the Physiological Threshold for Angina (ORBITA-FIRE): A Double-Blind, Randomized, Placebo-Controlled Study.
PubMed 文献 · Circulation · 2026-05-08

结果显示这些阈值高度个体化、随心负荷增加而升高,且均显著低于临床诊断切点,较低阈值与基线心绞痛负担更高及 PCI 后症状缓解更显著相关。

要点

  • 心绞痛阈值 FFRangina 和 RFRangina 显著低于临床诊断切点。
  • 阈值高度个体化,且随运动负荷增加而升高。
  • 较低阈值预测基线心绞痛负担更高和 PCI 后症状缓解更显著。

核心结论

  • 心绞痛生理阈值 FFRangina 和 RFRangina 高度个体化,随心负荷变化,且持续低于指导血运重建的通用缺血阈值。
  • 这些发现支持整合个体化、症状相关的生理学指标以优化患者选择和改善 PCI 症状反应。

研究设计与样本

  • PCI 后支架内球囊递增充气至静息心绞痛发作,并以安慰剂充气验证阈值,记录症状发作时 FFRangina 和 RFRangina。
  • 在低强度和高强度运动下重复方案,评估心绞痛阈值随心脏负荷的变化。

主要发现

  • 静息时 FFRangina 中位数 0.29(IQR 0.23-0.35),低强度运动时 0.38(IQR 0.30-0.48),高强度运动时 0.45(IQR 0.36-0.55)。
  • 静息时 RFRangina 中位数 0.22(IQR 0.16-0.30),低强度运动时 0.26(IQR 0.18-0.36),高强度运动时 0.32(IQR 0.23-0.46)。
  • 所有阈值均显著低于临床诊断切点(P<0.001)。
  • 较低的 FFRangina 和 RFRangina 阈值与静息、低强度和高强度运动条件下症状可重复性更高相关(FFRangina:P=0.008、P<0.001、P<0.001;RFRangina:P=0.015、P<0.001、P=0.002)。
  • 所有条件下较低的阈值预测更高的基线心绞痛负担和 PCI 后更显著的症状缓解(交互作用概率>0.999)。

临床怎么用

  • 心绞痛阈值远低于常规 FFR/RFR 缺血切点,提示症状导向的个体化生理评估可能优化 PCI 患者选择。
  • 较低的心绞痛阈值可能识别基线症状负担更重且 PCI 后症状缓解更明显的患者。
  • 运动负荷可升高心绞痛阈值,评估时应考虑患者的活动状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In stable coronary artery disease, the primary goal of percutaneous coronary intervention (PCI) is symptom relief. Fractional flow reserve (FFR) and nonhyperemic pressure ratios such as resting full-cycle ratio (RFR) are used to guide revascularization. Although these indices correlate with myocardial ischemia, they have never been validated against the onset of angina. The physiological thresholds for angina, FFRangina and RFRangina, angina (FFRangina at rest and during exercise remain undefined. METHODS: ORBITA-FIRE (Finding the Invasive Threshold for Symptom Relief in Exertional Angina) was a multicenter, double-blind, randomized, placebo-controlled study in patients with stable angina and single-vessel coronary artery disease. After imaging-guided PCI, an in-stent balloon was incrementally inflated until angina occurred at rest. This angina threshold was verified against placebo inflation, and corresponding FFRangina and RFRangina values were recorded at symptom onset. The protocol was repeated during low- and high-intensity exercise to assess changes in angina thresholds with increasing cardiac workload. RESULTS: Sixty-five patients were enrolled (mean age, 63.9±8.7 years; 74% male; 69% hypertensive; 23% diabetic; 91% with Canadian Cardiovascular Society class II-III angina). Median pre-PCI FFR was 0.59 (interquartile range [IQR], 0.46-0.70) and RFR was 0.61 (IQR, 0.40-0.82). Median FFRangina at rest was 0.29 (IQR, 0.23-0.35), increasing to 0.38 (IQR, 0.30-0.48) during low-intensity exercise and 0.45 (IQR, 0.36-0.55) during high-intensity exercise. RFRangina similarly increased from 0.22 (IQR, 0.16-0.30) at rest to 0.26 (IQR, 0.18-0.36) and 0.32 (IQR, 0.23-0.46) during low- and high-intensity exercise. All thresholds were significantly lower than clinical diagnostic cut points (P<0.001). Lower FFRangina and RFRangina thresholds were associated with greater symptom reproducibility across rest, low- and high-intensity exercise conditions (FFRangina: P=0.008, P<0.001, P<0.001, respectively; RFRangina: P=0.015, P<0.001, P=0.002, respectively). Lower angina thresholds across all conditions predicted higher baseline angina burden and greater symptom relief with PCI (probability of interaction >0.999). CONCLUSIONS: Physiological thresholds for angina, FFRangina and RFRangina, are highly individualized, vary with cardiac workload, and are consistently lower than the universal ischemia-based thresholds used to guide revascularization. These findings support integrating personalized, symptom-linked physiology to refine patient selection and to improve symptomatic response to PCI.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Ahmed-Jushuf F, Foley MJ, Chotai S, et al. Determining the Physiological Threshold for Angina (ORBITA-FIRE): A Double-Blind, Randomized, Placebo-Controlled Study. Circulation. 2026. PMID: 42100816. doi:10.1161/CIRCULATIONAHA.125.078738

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。